Holen Sie sich die Stockscreener-App
9.14
2.15%
-0.18
Schlusskurs vom Vortag:
$9.32
Offen:
$9.37
24-Stunden-Volumen:
141.96K
Relative Volume:
0.13
Marktkapitalisierung:
$727.35M
Einnahmen:
$116.30M
Nettoeinkommen (Verlust:
$17.73M
KGV:
43.52
EPS:
0.21
Netto-Cashflow:
$20.88M
1W Leistung:
-7.88%
1M Leistung:
-0.44%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$9.055
$9.485
1-Wochen-Bereich:
$9.055
$9.965
52-Wochen-Spanne:
$5.33
$14.69
Niagen Bioscience Inc Stock (NAGE) Company Profile
Firmenname
Niagen Bioscience Inc
Sektor
Branche
Telefon
310-388-6706
Adresse
10900 WILSHIRE BLVD, LOS ANGELES
Vergleichen Sie NAGE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
9.12 | 743.30M | 116.30M | 17.73M | 20.88M | 0.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
398.40 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.84 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.85 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
747.84 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.47 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-08-16 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-08-11 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2019-10-16 | Eingeleitet | Oppenheimer | Outperform |
| 2019-02-14 | Eingeleitet | B. Riley FBR | Buy |
| 2017-11-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-09-25 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-01-03 | Eingeleitet | Rodman & Renshaw | Buy |
Alle ansehen
Niagen Bioscience Inc Aktie (NAGE) Neueste Nachrichten
Will Niagen Bioscience Inc. outperform the market2025 Market Sentiment & AI Optimized Trade Strategies - Newser
What momentum shifts mean for Niagen Bioscience Inc.Market Performance Recap & Low Risk Growth Stock Ideas - Newser
Applying big data sentiment scoring on Niagen Bioscience Inc.Treasury Yields & Advanced Swing Trade Entry Alerts - Newser
Analyzing Niagen Bioscience Inc. with multi timeframe chartsProduct Launch & Technical Buy Zone Confirmation - Newser
Visual trend scoring systems applied to Niagen Bioscience Inc.July 2025 Big Picture & Safe Entry Momentum Stock Tips - Newser
Niagen Bioscience Inc. stock chart pattern explainedWeekly Trend Summary & Daily Volume Surge Signals - Newser
Niagen Bioscience (NASDAQ:NAGE) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Is Niagen Bioscience Inc. stock bottoming out2025 Historical Comparison & Daily Entry Point Trade Alerts - Newser
Can swing trading help recover from Niagen Bioscience Inc. lossesJuly 2025 Update & AI Driven Stock Reports - Newser
Will Niagen Bioscience Inc. bounce back from current supportFed Meeting & Weekly High Potential Stock Alerts - Newser
Real time scanner hits for Niagen Bioscience Inc. explainedPortfolio Growth Summary & Long-Term Growth Stock Strategies - Newser
How sensitive is Niagen Bioscience Inc. to inflationJuly 2025 Price Swings & Precise Buy Zone Identification - khodrobank.com
Can Niagen Bioscience Inc. deliver consistent EPS growthJuly 2025 Levels & Real-Time Price Movement Reports - khodrobank.com
Multi factor analysis applied to Niagen Bioscience Inc.2025 Winners & Losers & Weekly Return Optimization Alerts - Newser
Is it too late to sell Niagen Bioscience Inc.2025 Volatility Report & Verified Entry Point Signals - Newser
Published on: 2025-09-03 22:51:56 - Newser
Is Niagen Bioscience Inc. showing insider buyingQuarterly Risk Review & Entry Point Strategy Guides - khodrobank.com
Chart based exit strategy for Niagen Bioscience Inc.Gap Down & Long-Term Investment Growth Plans - Newser
Is Niagen Bioscience Inc. stock poised for growthCEO Change & Precise Entry and Exit Recommendations - Newser
Is a relief rally coming for Niagen Bioscience Inc. holdersMarket Performance Recap & Real-Time Sentiment Analysis - Newser
Real time alert setup for Niagen Bioscience Inc. performanceLayoff News & Safe Entry Point Alerts - Newser
How to use Fibonacci retracement on Niagen Bioscience Inc.2025 Major Catalysts & Capital Efficiency Focused Strategies - Newser
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Average Rating of "Buy" from Analysts - MarketBeat
Published on: 2025-09-03 01:58:14 - Newser
Does Niagen Bioscience Inc. show high probability of reboundGold Moves & Smart Swing Trading Techniques - Newser
Is Niagen Bioscience Inc. stock reversal real or fake2025 Price Targets & Technical Pattern Based Buy Signals - Newser
Using economic indicators to assess Niagen Bioscience Inc. potentialJuly 2025 PostEarnings & Verified Trade Idea Suggestions - Newser
Niagen Bioscience, Inc.'s (NASDAQ:NAGE) Intrinsic Value Is Potentially 91% Above Its Share Price - Yahoo Finance
Published on: 2025-09-02 10:16:45 - Newser
Historical volatility pattern of Niagen Bioscience Inc. visualizedWeekly Market Report & Daily Chart Pattern Signal Reports - Newser
Niagen Bioscience Inc. stock momentum explainedQuarterly Profit Summary & Weekly High Return Forecasts - Newser
Should you hold or exit Niagen Bioscience Inc. nowJuly 2025 Big Picture & Accurate Intraday Trading Signals - Newser
Key metrics from Niagen Bioscience Inc.’s quarterly dataMarket Risk Summary & Technical Pattern Based Signals - Newser
Is Niagen Bioscience Inc. forming a reversal pattern2025 Support & Resistance & Long-Term Growth Stock Strategies - Newser
Real time pattern detection on Niagen Bioscience Inc. stockInsider Selling & Stepwise Trade Execution Plans - Newser
Finanzdaten der Niagen Bioscience Inc-Aktie (NAGE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Niagen Bioscience Inc-Aktie (NAGE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Lopez Carlos Luis | SVP, General Counsel |
Mar 07 '25 |
Buy |
7.86 |
273 |
2,146 |
2,251 |
| Jaksch Frank L Jr | Director |
Dec 13 '24 |
Option Exercise |
3.66 |
50,001 |
183,004 |
281,340 |
| Jaksch Frank L Jr | Director |
Dec 13 '24 |
Sale |
6.19 |
37,161 |
229,956 |
244,179 |
0.23%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):